Peter Barrett - Net Worth and Insider Trading
Peter Barrett Net Worth
The estimated net worth of Peter Barrett is at least $3 Million dollars as of 2024-11-13. Peter Barrett is the Director of Revvity Inc and owns about 22,001 shares of Revvity Inc (RVTY) stock worth over $3 Million. Peter Barrett is also the Director, 10% Owner of Momenta Pharmaceuticals Inc and owns about 2,134 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $111,992. Details can be seen in Peter Barrett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Barrett has not made any transactions after 2020-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter Barrett
Peter Barrett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Barrett owns 7 companies in total, including Larimar Therapeutics Inc (LRMR) , Synlogic Inc (SYBX) , and Revvity Inc (RVTY) among others .
Click here to see the complete history of Peter Barrett’s form 4 insider trades.
Insider Ownership Summary of Peter Barrett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LRMR | Larimar Therapeutics Inc | 2015-07-13 | director & 10 percent owner |
| SYBX | Synlogic Inc | 2017-08-28 | director |
| RVTY | Revvity Inc | 2020-05-28 | director |
 | | 2014-09-29 | director |
| | 2012-06-07 | director |
| | 2008-06-05 | director |
| | 2004-05-27 | director |
Peter Barrett Latest Holdings Summary
Peter Barrett currently owns a total of 2 stocks. Among these stocks, Peter Barrett owns 22,001 shares of Revvity Inc (RVTY) as of May 28, 2020, with a value of $3 Million and a weighting of 95.94%. Peter Barrett also owns 2,134 shares of Momenta Pharmaceuticals Inc (MNTA) as of June 21, 2004, with a value of $111,992 and a weighting of 4.06%.
Latest Holdings of Peter Barrett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVTY | Revvity Inc | 2020-05-28 | 22,001 | 120.35 | 2,647,820 |
| MNTA | Momenta Pharmaceuticals Inc | 2004-06-21 | 2,134 | 52.48 | 111,992 |
Holding Weightings of Peter Barrett
Peter Barrett Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Barrett has made a total of 1 transactions in Revvity Inc (RVTY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Revvity Inc is the sale of 7,552 shares on May 28, 2020, which brought Peter Barrett around $756,031.
According to the SEC Form 4 filings, Peter Barrett has made a total of 0 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years. The most-recent trade in Momenta Pharmaceuticals Inc is the acquisition of 122,000 shares on June 21, 2004, which cost Peter Barrett around $793,000.
Insider Trading History of Peter Barrett
- 1
Peter Barrett Trading Performance
GuruFocus tracks the stock performance after each of Peter Barrett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Barrett is 11.4%. GuruFocus also compares Peter Barrett's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Barrett within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter Barrett's insider trading performs compared to the benchmark.
Performance of Peter Barrett
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.23 | | | | | |
| Relative Return to S&P 500(%) | 7.43 | | | | | |
Peter Barrett Ownership Network
Ownership Network List of Peter Barrett
Ownership Network Relation of Peter Barrett
Peter Barrett Owned Company Details
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Peter Barrett is the director & 10 percent owner of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc (LRMR) Insider Trades Summary
Over the past 18 months, Peter Barrett made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 57,208 shares made by Thomas Edward Hamilton , and a net purchase of 5,000 shares made by Carole Ben-maimon .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,367,575 shares were bought by its insiders, resulting in a net purchase of 4,367,575 shares.
Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
Peter Barrett Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Barrett. You might contact Peter Barrett via mailing address: C/o Alnylam Pharmaceuticals, Inc., 300 Third Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
